Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics announced a $105 million Series C round ...
Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round. The ...
Series C proceeds position Spectris for pivotal top-line data, regulatory submission, and launch planning ahead of a targeted 2027 U.S. market entry. Spectris delivers coordinated visual and auditory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results